Factors Influencing Physicians in the Adoption of E-Detailing in the in-Vitro Diagnostic Industry


  • Anne Jillian Castillo The Graduate School, University of Santo Tomas, Espana Boulevard, 1015 Manila, Philippines
  • Ernesto Dimaculangan The Graduate School, University of Santo Tomas, Espana Boulevard, 1015 Manila, Philippines




E-detailing, IVD, Physicians


The pandemic has hastened the need for in-vitro diagnostic (IVD) companies to blend digital and traditional sales strategies. This study explores factors influencing physicians’ adoption of e-detailing in the IVD industry. Dependent variables include physicians’ perceptions and intention to use e-detailing, while independent variables encompass the socio-demographic characteristics of the respondents. Physicians’ perceptions were also explored if they influenced intentions to use e-detailing. The study excluded physicians outside the National Capital Region and those not involved in patient consultations. With 408 participants, descriptive statistics and Structural Equation Modeling were utilized to identify sociodemographic characteristics influencing physicians’ perceptions, behavioral intentions, and intention to use e-detailing. A thematic analysis was used to identify common themes doctors use to obtain information about IVD tests. Approximately 76% of respondents find e-detailing advantageous, with 70% agreeing on its compatibility and 80% believing it is easy to use. The majority (77%) consider using e-detailing to stay updated on in-vitro diagnostic tests, and 75% intend to use it regularly in the future to obtain such information. However, only 43% express a willingness to switch from face-to-face detailing. More than half of the respondents (52%) prefer to use a combination of face-to-face visits and e-detailing. The study found that the years of medical practice and the medical hierarchy significantly influenced physicians’ perceptions of adopting e-detailing. Physicians who viewed e-detailing as advantageous, compatible with their professional needs, and less complex were more inclined to adopt the digital tool for their practice. However, demographic factors did not significantly affect physicians’ intentions regarding e-detailing. This study recommends creating high-quality e-detailing materials for Filipino physicians, ensuring accessibility, personalizing content, incorporating multimedia, promoting two-way communication, regularly updating, offering expert interaction, and continuously collecting physician feedback.


Download data is not yet available.


Abolfotouh, M. A., BaniMustafa, A., Salam, M., Al-Assiri, M., Aldebasi, B., & Bushnak, I. (2019). Use of smartphone and perception towards the usefulness and practicality of its medical applications among healthcare workers in Saudi Arabia. BMC Health Services Research, 19(1). https://doi.org/10.1186/s12913-019-4523-1

Accenture Healthcare Provider Survey. (2020, May). Reinventing relevance: New models for pharma engagement with healthcare providers in a COVID-19 world. https://www.accenture.com/_acnmedia/PDF-131/Accenture-COVID-19-Pulse-Survey-Wave7.pdf

Adkonkar, A., Angrish, A. K., & Bansal, S. K. (2022). A paradigm shift in pharmaceutical marketing. Paradigm Shift in Marketing and Finance, 107.

Ajuwon, G. A., & Popoola, S. O. (2015). Influence of motivational factors on utilisation of Internet health information resources by resident doctors in Nigeria. The Electronic Library, 33(1), 103–119. https://doi.org/10.1108/el-12-2012-0159

Akbarieh, A., Jayasinghe, L. B., Waldmann, D., & Teferle, F. N. (2020). BIM-based end-of-lifecycle decision making and digital deconstruction: Literature review. Sustainability, 12(7), 2670.

Alam, S., Omar, N., Mohd Ariffin, A., & Nik Hashim, N. (2018). Integrating TPB, TAM and DOI theories: An empirical evidence for the adoption of mobile banking among customers in Klang Valley, Malaysia. International Journal of Business & Management Science, 8(2).

Al-Areefi, M. A., Hassali, M. A., & b Mohamed Ibrahim, M. I. (2013). Physicians’ perceptions of medical representative visits in Yemen: A qualitative study. BMC Health Services Research, 13(1). https://doi.org/10.1186/1472-6963-13-331

Alkhateeb, F. M., & Doucette, W. R. (2009). Influences on physicians’ adoption of electronic detailing (e-detailing). Informatics for Health and Social Care, 34(1), 39–52. https://doi.org/10.1080/17538150902779402

Anagostou, A., & Liotta, L. A. (2012). Small business development for molecular diagnostics. Methods in Molecular Biology, 421–437. https://doi.org/10.1007/978-1-60327-216-2_28

Balkanski, S., & Getov, I. (2020). E-detailing: Keyways for successful implementation of digital technologies in the pharmaceutical marketing. Promotion and Marketing Communications, 1. https://doi.org/10.5772/intechopen.89249

Banerjee, S., & Dash, S. K. (2011). Effectiveness of e-detailing as an innovative pharmaceutical marketing tool in emerging economies: Views of health care professionals of India. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 11(3), 204–214. https://doi.org/10.1177/1745790411413631

Batongbakal, L. (2020). How to become a doctor in the Philippines: An ultimate guide. Filipiknow. https://filipiknow.net/how-to-become-a-doctor-in-the-philippines/#easy-footnote-bottom-7-16888

Bigtincan Holdings Limited. (2023). What is e-detailing? Advantages for pharma marketers | Bigtincan. Bigtincan. Retrieved September 10, 2023, from https://www.bigtincan.com/what-is-e-detailing/

Bounthavong, M., Shayegani, R., Manning, J. M., Marin, J., Spoutz, P., Hoffman, J. D., ... & Christopher, M. L. (2022). Comparison of virtual to in-person academic detailing on naloxone prescribing rates at three US Veterans Health Administration regional networks. International Journal of Medical Informatics, 161, 104712.

Broomfield, R. (2015). A nurses’ guide to quantitative research. Australian Journal of Advanced Nursing, 32(2).

Caffery, L. J., Martin-Khan, M., & Wade, V. (2016). Mixed methods for telehealth research. Journal of Telemedicine and Telecare, 23(9), 764–769. https://doi.org/10.1177/1357633x16665684

Center for Devices and Radiological Health. (2019, October 25). In-vitro diagnostics. U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/products-and-medical-procedures/vitro-diagnostics

Davis, A. M. (2014). Medical writing for in vitro diagnostics: A different approach for the ‘hidden’ side of healthcare. Medical Writing, 23(3), 204–206. https://doi.org/10.1179/2047480614z.000000000227

Davis, F. D. (1989). Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly, 13(3), 319. https://doi.org/10.2307/249008

DeciBio Consulting, LLC. (2016). In vitro diagnostics (IVD) market size, growth, competition and trends (2012- 2018). https://www.decibio.com/wp-content/uploads/2019/06/IVD-Market-Report_Published_31JAN2016_TOC.pdf

De Grood, C., Raissi, A., Kwon, Y., & Santana, M. (2016). Adoption of e-health technology by physicians: A scoping review. Journal of Multidisciplinary Healthcare, 9, 335–344. https://doi.org/10.2147/jmdh.s103881

Department of Health. (N.D.). What is a highly urbanized city (HUC)? Https://doh.gov.ph/. Retrieved May 17, 2021, from https://doh.gov.ph/node/1391

Diamond, L., Busch, M., Jilch, V., & Tscheligi, M. (2018). Using technology acceptance models for product development. Proceedings of the 20th International Conference on Human-Computer Interaction with Mobile Devices and Services Adjunct. Published. https://doi.org/10.1145/3236112.3236175

Dockendorf, M. F., Hansen, B. J., Bateman, K. P., Moyer, M., Shah, J. K., & Shipley, L. A. (2021). Digitally enabled, patient‐centric clinical trials: Shifting the drug development paradigm. Clinical and Translational Science, 14(2), 445–459.

Ducharme, J. (2020, March 11). World Health Organization declares COVID-19 a “pandemic.” Here’s what that means. Time. https://time.com/5791661/who-coronavirus-pandemic-declaration/

Duddy, C., & Wong, G. (2021). Efficiency over thoroughness in laboratory testing decision making in primary care: Findings from a realist review. BJGP Open, 5(2). https://doi.org/10.3399/bjgpopen20x101146

Dwivedi, Y. K., Ismagilova, E., Hughes, D. L., Carlson, J., Filieri, R., Jacobson, J., Jain, V., Karjaluoto, H., Kefi, H., Krishen, A. S., Kumar, V., Rahman, M. M., Raman, R., Rauschnabel, P. A., Rowley, J., Salo, J., Tran, G. A., & Wang, Y. (2021). Setting the future of digital and social media marketing research: Perspectives and research propositions. International Journal of Information Management, 59, 102168. https://doi.org/10.1016/j.ijinfomgt.2020.102168

Eitel, D. R. (1998). Use of Internet technology by obstetricians and family physicians. JAMA: The Journal of the American Medical Association, 280(15), 1306–1307. https://doi.org/10.1001/jama.280.15.1306

Emani, S., Peters, E., Desai, S., Karson, A. S., Lipsitz, S. R., LaRocca, R., Stone, J., Suric, V., Wald, J. S., Wheeler, A., Williams, D. H., & Bates, D. W. (2018). Perceptions of adopters versus non-adopters of a patient portal: An application of diffusion of innovation theory. BMJ Health & Care Informatics, 25(3), 149–157. https://doi.org/10.14236/jhi.v25i3.991

Engel, J. (2018, October 3). What is digital transformation? Salesforce Blog. https://www.salesforce.com/blog/what-is-digital-transformation/

Filipino Doctors. (2020). How to become a doctor in the Philippines: An ultimate guide. Filipiknow. https://filipiknow.net/how-to-become-a-doctor-in-the-philippines/#easy-footnote-bottom-7-16888

Fortune Business Insights. (2020, May 21). U.S. digital therapeutics market size, share and industry analysis, by application (diabetes, obesity, cardiovascular disease (CVD), central nervous system (CNS) disease, gastrointestinal disorder, respiratory disease, smoking cessation, and others), by end-user (patients, providers, payers, and employers), and regional forecast, 2019–2026. https://www.fortunebusinessinsights.com/u-s-digital-therapeutics-market-102225

Fuchs, C., Fischer, P., & Krabel, S. (2010). Endogenous time pressure in patent evaluation: An empirical analysis of the effects on patent quality. R&D Management, 40(2), 138–161. https://doi.org/10.1111/j.1467-9310.2010.00589.x

Garthwaite, C. L., & Ody, C. (2018). The best price we can get: Price search and pharmaceutical bargaining under monopsony. Review of Economics and Statistics, 101(1), 165–180.

Greenhalgh, T., Robert, G., MacFarlane, F., Bate, P., & Kyriakidou, O. (2004). Diffusion of innovations in service organizations: Systematic review and recommendations. The Milbank Quarterly, 82(4), 581–629. https://doi.org/10.1111/j.0887-378x.2004.00325.x

Hart, J., Blackstone, M., Jones, G., & James, P. (2008). Medical e-detailing: The potential for change. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 8(2), 107–113. https://doi.org/10.1057/palgrave.jmm.5050156

Heeks, R., & Stanforth, C. (2007). Understanding e-government project trajectories from an actor-network perspective. European Journal of Information Systems, 16(2), 165–177. https://doi.org/10.1057/palgrave.ejis.3000676

Ilatova, S. (2020). Digital transformation of pharmaceutical companies in Russia. International Journal of Advanced Studies, 10(3), 43–46. https://doi.org/10.12731/2227-930x-2020-10-3-43-46

Iluyemi, A. (2009). Towards a comprehensive framework for deploying ICT in healthcare in developing countries. International Journal of Computing and ICT Research, 3(2).

Ioannidis, J. P. A., & Stuart, M. E. (2022). Rethinking the use of clinical trial data. Science, 375(6583), 1003–1004. https://doi.org/10.1126/science.abm9271

Jenkins, R. (2020). Reengineering pharma’s go-to-market model during the pandemic. Pharmaceutical Commerce. https://www.pharmaceuticalcommerce.com/view/reengineering-pharma-s-go-to-market-model-during-the-pandemic

Johnston, D. W. (2018). The effects of time pressure and task complexity on health professionals’ decisions about treatment options. Journal of Health Services Research & Policy, 23(1), 25–32. https://doi.org/10.1177/1355819617751697

Kaushik, V., & Walsh, C. A. (2019). Pragmatism as a research paradigm and its implications for social work research. Social Sciences, 8(9), 255. https://doi.org/10.3390/socsci8090255

Kibria, G. (2020, October 2). ‘E-detailing’ can be the game changer for pharmaceutical companies during COVID-19. Edge and Corner. https://www.edgeandcorner.com/e-detailing-can-be-the-game-changer-for-pharmaceutical-companies-during-covid-19/

Kibria, G., Hossain, S., & Mollah, M. N. H. (2020). ‘E-detailing’ can be the game changer for pharmaceutical companies during COVID-19. Journal of Pharmaceutical Policy and Practice, 13(1). https://doi.org/10.1186/s40545-020-00237-0

Kirsty, L., & Robert, W. (2016). E-detailing: An emerging innovation in the pharmaceutical industry. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 13(2), 125–136. https://doi.org/10.1177/1745790413486588

Krasniqi, A., & Hajrizi, E. (2018). Opportunities and challenges of digital transformation for manufacturing SMEs. MATEC Web of Conferences, 252, 06007. https://doi.org/10.1051/matecconf/201825206007

Lähteenmäki, R., & Nätti, S. (2013). Obstacles to digital marketing in pharmaceutical companies. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 13(4), 213–219. https://doi.org/10.1177/1745790413498270

Lau, B., & Aggarwal, N. (2021). Introduction: The digital transformation of health care. In Machine Learning and Artificial Intelligence for Healthcare Applications (pp. 1–24). https://doi.org/10.1002/9781119710126.ch1

Laverty, M., & Sabharwal, R. (2021). Rethinking medical practice: The future of digital therapeutics. Journal of Medical Internet Research, 23(3), e25824. https://doi.org/10.2196/25824

Mack, C. (2020). The importance of understanding the patient journey in digital health innovation. Journal of Medical Internet Research, 22(1), e16468. https://doi.org/10.2196/16468

McMullan, M. (2006). Patients using the Internet to obtain health information: How this affects the patient-health professional relationship. Patient Education and Counseling, 63(1-2), 24–28. https://doi.org/10.1016/j.pec.2005.10.006

Mettler, T., & Vimarlund, V. (2009). Understanding business models in e-health. A Mixed Methods Analysis, 8(4), 344–358. https://doi.org/10.4018/jebr.2009092901

Mohsin, M. (2022, August 15). 10 Amazon statistics you need to know in 2022. Oberlo. https://www.oberlo.com/blog/amazon-statistics

Moretti, A., & Tuan, A. (2013). The social enterprise as a driver for the digital transformation of health care. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 13(4), 221–229. https://doi.org/10.1177/1745790413498271

Omar, M., Omar, S., & Omar, N. (2016). How to choose the best e-detailing solution for your pharma business. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 13(3), 181–190. https://doi.org/10.1177/1745790413486584

Opresnik, D., & Taisch, M. (2015). The value of big data in servitization. International Journal of Production Economics, 165, 174–184. https://doi.org/10.1016/j.ijpe.2014.12.036

Panigrahi, N., Sahu, P. K., & Tummala, R. (2018). Health care goes digital: A journey from evolution to transformation. Health Policy and Technology, 7(3), 278–291. https://doi.org/10.1016/j.hlpt.2018.06.002

Pappu, S., & Zheng, Y. (2020). Regulatory framework and guidelines for medical devices in the United States. In Handbook of Medical Device Regulatory Affairs in Asia (pp. 275–302). https://doi.org/10.1201/9780429328700-10

Porter, M. E., & Teisberg, E. O. (2006). Redefining health care: Creating value-based competition on results. Harvard Business Review Press.

Raghupathi, W., & Raghupathi, V. (2014). Big data analytics in healthcare: Promise and potential. Health Information Science and Systems, 2(1), 3. https://doi.org/10.1186/2047-2501-2-3

Randhawa, P. (2020, August 11). How the pharmaceutical industry is evolving with the times. Medium. https://medium.com/@prachi.randhawa/how-the-pharmaceutical-industry-is-evolving-with-the-times-fae6ac92f250

Salesforce Blog. (2018, October 3). What is digital transformation? https://www.salesforce.com/blog/what-is-digital-transformation/

Sampietro, G., & Comino, S. (2016). Patent protection, patent quality, and innovation in the pharmaceutical industry. International Journal of Health Economics and Management, 16(2), 177–200. https://doi.org/10.1007/s10754-016-9191-6

Sampietro, G., & Galli, M. (2015). The value of patents for today’s economy. Technology in Society, 43, 97–104. https://doi.org/10.1016/j.techsoc.2015.08.001

Shah, N. (2019, April 25). How digital therapeutics can transform the treatment of diabetes. HealthTech. https://healthtechmagazine.net/article/2019/04/how-digital-therapeutics-can-transform-treatment-diabetes

Singh, D. (2018). Digital transformation in healthcare: Emerging trends and opportunities. International Journal of Medical Informatics, 120, 14–21. https://doi.org/10.1016/j.ijmedinf.2018.08.005

Sulaiman, S. S. (2021). Challenges in digital transformation for pharmaceutical companies in Malaysia. Asian Journal of Business and Accounting, 14(1), 101–120. https://doi.org/10.22452/ajba.vol14no1.5

Van de Ven, A. H., & Huber, G. P. (1990). Longitudinal field research methods for studying processes of organizational change. Organization Science, 1(3), 213–219. https://doi.org/10.1287/orsc.1.3.213

Walker, A. (2019, April 11). The impact of digital health on healthcare: An overview of the current and future landscape. Journal of Medical Internet Research, 21(4), e12843. https://doi.org/10.2196/12843

Winter, S., Berente, N., Howison, J., & Butler, B. S. (2014). Beyond the organizational ‘container’: Conceptualizing 21st century sociotechnical work. Information and Organization, 24(4), 250–269. https://doi.org/10.1016/j.infoandorg.2014.10.001

Yin, R. K. (2017). Case study research and applications: Design and methods. Sage Publications.




How to Cite

Castillo, A. J., & Dimaculangan, E. (2024). Factors Influencing Physicians in the Adoption of E-Detailing in the in-Vitro Diagnostic Industry. American Journal of Medical Science and Innovation, 3(1), 134–152. https://doi.org/10.54536/ajmsi.v3i1.2978